Overview
VRTX market data
Price History
VRTX price chart · 1M
- O
- 550.50
- H
- 551.84
- L
- 546.44
- C
- 547.60
- Vol
- 33,345.00
- Source
- US equities market feed
- Observed
- Aug 26, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $550.50
- Previous Close
- $553.04
- Day High
- $551.84
- Day Low
- $546.44
- 52 Week High
- $555.42
- 52 Week Low
- $412.60
- 7 Day Return
- -0.79%
- 30 Day Return
- +14.36%
- 90 Day Return
- +22.27%
- 1 Year Return
- +19.90%
- Daily Notional Volume
- $18.3M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- 30.70 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $15.32 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.27 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 35.0% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $374.17 – $555.69 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $135.2B · P/B 6.16 · P/S 10.74.
Company News
Live On CNBC, Karen Firestone Announces Bought Vertex PharmaceuticalsBenzinga · Aug 25, 2026, 4:31 PM
Uber, ServiceNow And A Health Care Stock On CNBC’s ‘Final Trades’Benzinga · Aug 21, 2026, 12:19 PM
IBBQ vs. PBE: Which Biotech ETF Is the Better Buy?The Motley Fool · Aug 21, 2026, 12:15 PM
Vertex Pharmaceuticals' Rally Has a New Engine -- and Wall Street Thinks the Best Is Still AheadThe Motley Fool · Aug 20, 2026, 8:15 PM
CNBC Halftime Report Final Trades: ServiceNow, Uber Technologies, Vertex PharmaceuticalsBenzinga · Aug 20, 2026, 5:01 PM
Invesco Nasdaq Biotech vs. Invesco Pharma: How Do These ETFs Stack Up?The Motley Fool · Aug 19, 2026, 12:15 PM
State Street XLV vs VanEck BBH: Which Healthcare ETF Is the Better Buy in 2026?The Motley Fool · Aug 5, 2026, 8:15 PM
Truist Securities Maintains Buy on Vertex Pharmaceuticals, Raises Price Target to $565Benzinga · Aug 5, 2026, 6:04 PM
Barclays Maintains Overweight on Vertex Pharmaceuticals, Raises Price Target to $617Benzinga · Aug 5, 2026, 1:30 PM
TD Cowen Maintains Buy on Vertex Pharmaceuticals, Raises Price Target to $550Benzinga · Aug 4, 2026, 4:28 PM